1. Non–Guideline-concordant Treatment of Testicular Cancer Is Associated With Reduced Relapse-free Survival
    Pia Paffenholz et al, 2017, Clinical Genitourinary Cancer CrossRef
  2. Is the FSHR 2039A>G variant associated with susceptibility to testicular germ cell cancer?
    A. K. Bang et al, 2017, Andrology CrossRef
  3. Testicular germ-cell tumours and penile squamous cell carcinoma: appropriate management makes the difference
    Nicola Nicolai et al, 2018, European Journal of Surgical Oncology CrossRef
  4. Testis-Sparing Surgery in Patients with Germ Cell Cancer: Indications and Clinical Outcome
    David Pfister et al, 2018, Oncol Res Treat CrossRef
  5. Interdisciplinary Management of Testicular Germ Cell Tumors - More Needed than Ever!
    Axel Heidenreich, 2018, Oncol Res Treat CrossRef
  6. Grenzen der Chirurgie in der Uroonkologie
    A. Heidenreich, 2018, Urologe CrossRef
  7. Treatment of Clinical Stage II (CS II) Disease in Testicular Cancer
    Christian Winter, 2019 CrossRef
  8. Second Opinions in Psychiatry
    SABINA C. HEUSS et al, 2018, Journal of Psychiatric Practice CrossRef
  9. Treatment of Clinical Stage II (CS II) Disease in Testicular Cancer
    Christian Winter, 2019 CrossRef
  10. Zweitmeinungsnetz zu Hodentumoren wird häufig genutzt
    Robert Bublak et al, 2014, Uro-News CrossRef
  11. Das deutsche Zweitmeinungsnetz zu Hodentumoren wird häufig genutzt
    Robert Bublak et al, 2014, Im Focus Onkologie CrossRef
  12. Nachsorge urologischer Tumorbehandlungen
    C.-H. Ohlmann et al, 2015, Urologe CrossRef
  13. Guidelines on Testicular Cancer: 2015 Update
    Peter Albers et al, 2015, European Urology CrossRef
  14. Is there evidence for a better health care for cancer patients after a second opinion? A systematic review
    Dana Ruetters et al, 2016, J Cancer Res Clin Oncol CrossRef
  15. Information Deficits and Second Opinion Seeking – A Survey on Cancer Patients
    Tobias Fuchs et al, 2017, Cancer Investigation CrossRef
  16. GeSRU-Hodentumor-App
    P. Paffenholz et al, 2017, Urologe CrossRef
  17. Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey
    F. A. Distler et al, 2019, World J Urol CrossRef
  18. Outcome Assessment for a Telemedicine-Based Second Opinion Program for Midwest China
    Ayan Mao et al, 2020, INQUIRY CrossRef
  19. So, now what?: Reflections on socioeconomic factors, testicular cancer, and health care accessibility
    Michael J. Rovito et al, 2021, Cancer CrossRef
  20. Assessing quality of care in the diagnosis and treatment of early-stage testicular cancer: A critical review and summary
    Mitchell M. Huang et al, 2021, Urologic Oncology: Seminars and Original Investigations CrossRef
  21. Novel Program Offering Remote, Asynchronous Subspecialist Input in Thoracic Oncology: Early Experience and Insights Gained During the COVID-19 Pandemic
    Howard (Jack) West et al, 2021, JCO Oncology Practice CrossRef
  22. Guideline discordant care in patients with metastatic germ cell tumors
    John K Lin et al, 2022, Urologic Oncology: Seminars and Original Investigations CrossRef
  23. Seminoma Clinical Stage 1 - Patterns of Care in Germany
    Klaus-Peter Dieckmann et al, 2016, Urol Int CrossRef
  24. Multimodale Therapie des Hodentumors: wann Chemotherapie, Operation oder Strahlentherapie?
    Tim Nestler et al, 2022, Urologie CrossRef
  25. Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment
    Matthäus Majewski et al, 2023, Cancer Medicine CrossRef
  26. Testicular germ cell tumours: Outcomes at a tertiary hospital in the Western Cape, South Africa
    Gérard Grobler et al, 2023, South African Journal of Oncology CrossRef
  27. Regionalization of Testis Cancer Care—Is It Necessary?
    Axel Heidenreich et al, 2024, Urologic Clinics of North America CrossRef
  28. Testicular Cancer Survivorship and Fertility Preservation
    Aaron Tverye et al, 2024, Urologic Clinics of North America CrossRef
  29. miR-21, miR-29a, and miR-106b: serum and tissue biomarkers with diagnostic potential in metastatic testicular cancer
    Zsuzsanna Ujfaludi et al, 2024, Sci Rep CrossRef